Physician profile
Tommy G Roe
NPI 1720077050
$3,283.01
in general payments reported to CMS, 2019-2025
12 companies · $988 in 2025
The $988 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $69.24 · 2021: $71.05 · 2022: $358 · 2023: $775 · 2024: $377 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,022 · Travel and Lodging: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,021.67 |
| Travel and Lodging | $117.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,145.89 | 2021-2025 | Ortholoc 3di, Prophecy, Actishield |
| Smith+Nephew, INC. | $714.20 | 2019-2025 | Grafix Pl, Stravix Pl, Grafix |
| Kerecis Limited | $557.77 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Treace Medical Concepts, INC. | $256.20 | 2025 | |
| Rikco International, LLC | $173.00 | 2019 | |
| Organogenesis INC. | $153.53 | 2019-2024 | |
| Djo, LLC | $96.04 | 2019 | |
| Wright Medical Technology, INC. | $81.18 | 2019-2020 | |
| Depuy Synthes Sales INC. | $51.72 | 2025 | Quickanchor Ethibond, Dynacord |
| Medtronic, INC. | $18.27 | 2021 | |
| Bioventus LLC | $17.66 | 2022 | |
| Gemini Mountain Medical, LLC | $17.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tommy Roe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.